These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Is the anxiety about Ecstasy justified?]. Möller-Nehring E, Luderer HJ. Fortschr Med; 1997 Mar 10; 115(7):28, 31-2, 34. PubMed ID: 9173018 [Abstract] [Full Text] [Related]
15. Club drug use in Germany. Soellner R. Subst Use Misuse; 2005 Mar 10; 40(9-10):1279-93. PubMed ID: 16048817 [Abstract] [Full Text] [Related]
16. Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option. Garbino J, Henry JA, Mentha G, Romand JA. Vet Hum Toxicol; 2001 Apr 10; 43(2):99-102. PubMed ID: 11308131 [Abstract] [Full Text] [Related]
17. Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature. Uys JD, Niesink RJ. Drug Alcohol Rev; 2005 Jul 10; 24(4):359-68. PubMed ID: 16234132 [Abstract] [Full Text] [Related]
19. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy"). Cohen RS. Biol Psychiatry; 1996 May 01; 39(9):819-20. PubMed ID: 8731525 [No Abstract] [Full Text] [Related]